MedTrace Logo

The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening

NCT05516927 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 788

Last updated 2024-11-06

No results posted yet for this study

Summary

This protocol is a prospective, case-control multi-center diagnostic study to assess the sensitivity and specificity of blood-based screening tests for the early detection of multiple cancers.

Conditions

  • Newly-diagnosed Cancers
  • Non-cancer Controls

Interventions

DIAGNOSTIC_TEST

Freenome Test

Participants who provide informed consent, meet the eligibility criteria and provide a blood sample for this study will be enrolled.

Sponsors & Collaborators

  • Freenome Holdings Inc.

    lead INDUSTRY

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-06
Primary Completion
2023-12-20
Completion
2024-05-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05516927 on ClinicalTrials.gov